Search - tctmd.com

Displaying 141 - 160 of 538

Sort: Relevancy | Date

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Industry News

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

October 15, 2015

News Industry News

Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

Presentation TCT 2015

FDA-Approved or US IDE Studies: SAPIEN 3 - Technical Specifications and Clinical Trial Results (CE Studies and PARTNER II S3HR and S3i)

Presenter: Ariel Finkelstein, Ganesh Manoharan, Susheel Kodali

October 14, 2015

Presentation TCT 2015

TCT 95: The Long-term Hemodynamic Performance of Transcatheter Aortic Valve Replacement A Report From the PARTNER I Trial

Presenter: Jeffrey J. Popma, Mathew Williams, Melissa Daubert

October 13, 2015

Presentation TCT 2015

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

Presenter: Jeffrey J. Popma, Mathew Williams, Nirat Beohar

October 13, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

Presentation TCT 2015

Case 3: Diamond Isn't Everything! (Difficult Rotablation With Insufficient Rotawire Landing Zone)

Presenter: George D. Dangas, Paul Hsien-Li Kao, Po-Ming Ku

October 11, 2015

Presentation TCT 2015

Case 3 Resolution: How We Treated Our Patient

Presenter: Francesco Bedogni, Sergio Berti, Olaf Franzen

October 11, 2015

Presentation TCT 2015

Case 3 Introduction: A Complication During MitraClip Implantation

Presenter: Francesco Bedogni, Sergio Berti, Olaf Franzen

October 11, 2015

Presentation TCT 2015

Case Presentation 3: LM Bifurcation

Presenter: Praveer Agarwal, Amal Kumar Banerjee, Narenda N. Khanna, Ajay J. Kirtane, Lekha R.A. Pathak, N. Prathapkumar, Gokul M. Reddy

October 11, 2015

Presentation TCT 2015

Update of PCI vs CABG for Left Main PCI (Beyond SYNTAX, PRECOMBAT, BEST, and Meta-analysis 2015): What's Different From 3-Vessel Disease?

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Case 3: A TAVR Complication

Presenter: Carlo Di Mario, Eberhard Grube, Didier Tchetche

October 11, 2015

Presentation TCT 2015

Updates From the PARTNER Trials 2: Reports From Selected Substudies

Presenter: Samir R. Kapadia, Jeffrey J. Popma, Darshan Doshi

October 11, 2015

Presentation TCT 2015

Updates From the PARTNER Trials 1: Follow-up From the Inoperable and High-Risk Subgroups

Presenter: Samir R. Kapadia, Jeffrey J. Popma

October 11, 2015

Presentation TCT 2015

Status Update on Moderate-Risk TAVR RCTs 1: PARTNER IIA

Presenter: Martin B. Leon, Neil E. Moat

October 11, 2015

Presentation TCT 2015

NSTE-ACS Case Presentation: From Presentation Through Discharge

Presenter: Ajay J. Kirtane, Gary S. Mintz, Manish A. Parikh, Bo Xu, Qi Zhang

October 11, 2015

Presentation TCT 2015

STEMI Case Presentation With MVD: From Presentation Through Discharge

Presenter: Ajay J. Kirtane, Gary S. Mintz, Manish A. Parikh, Bo Xu, Sreenivas Arramraju Kumar

October 11, 2015

Presentation TCT 2015

Complex PCI Case Presentation: Indications to Treatment

Presenter: Ajay J. Kirtane, Gary S. Mintz, Manish A. Parikh, Bo Xu

October 11, 2015

Advertisement

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Favorable Results At One Year With Newest Generation Of Balloon-Expandable Transcatheter Aortic Valve In High-Risk And Inoperable Patients With Aortic Stenosis

Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

FDA-Approved or US IDE Studies: SAPIEN 3 - Technical Specifications and Clinical Trial Results (CE Studies and PARTNER II S3HR and S3i)

TCT 95: The Long-term Hemodynamic Performance of Transcatheter Aortic Valve Replacement A Report From the PARTNER I Trial

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

Case 3: Diamond Isn't Everything! (Difficult Rotablation With Insufficient Rotawire Landing Zone)

Case 3 Resolution: How We Treated Our Patient

Case 3 Introduction: A Complication During MitraClip Implantation

Case Presentation 3: LM Bifurcation

Update of PCI vs CABG for Left Main PCI (Beyond SYNTAX, PRECOMBAT, BEST, and Meta-analysis 2015): What's Different From 3-Vessel Disease?

Case 3: A TAVR Complication

Updates From the PARTNER Trials 2: Reports From Selected Substudies

Updates From the PARTNER Trials 1: Follow-up From the Inoperable and High-Risk Subgroups

Status Update on Moderate-Risk TAVR RCTs 1: PARTNER IIA

NSTE-ACS Case Presentation: From Presentation Through Discharge

STEMI Case Presentation With MVD: From Presentation Through Discharge

Complex PCI Case Presentation: Indications to Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content